• Aucun résultat trouvé

Trial watch: TLR3 agonists in cancer therapy

N/A
N/A
Protected

Academic year: 2021

Partager "Trial watch: TLR3 agonists in cancer therapy"

Copied!
15
0
0

Texte intégral

Références

Documents relatifs

Microbial interventionSponsorNCTTherapeutic interventionCancer typePhasePrimary EndpointSecondary Endpoint Clinical Trials investigating the capacity of the gut microbiota to

GK is supported by the Ligue contre le Cancer (équipe labellisée); Agence National de la Recherche (ANR) – Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research

Et pourtant, après l’étude des liens entre corps et extensions de Pólya dans le cas d’extensions non ramifiées, nous serons en mesure de donner une réponse positive au problème

Classically, the discrete time process is embedded in a continuous time multitype branching process; the idea of embedding discrete urn models in continuous time branching

A defined search strategy was undertaken using the following terms: postmenopausal women, older women, breast cancer, early breast cancer, adjuvant therapy, tamoxifen,

The study includes the diffusion approximations of the P´ olya-Friedman proportion process and of its associated population gap random walk; it follows the path used in the

According to the point of view of the French mathematicians who participated to the conference, a number of topics on which Iraqi mathematicians are doing research is not connected

The characteristics of human NKT cells in lung cancer – CD1d independent cytotoxicity against lung cancer cells by NKT  cells and decreased human NKT cell response in lung